Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will ...
Pelage Pharmaceuticals has raised nearly $17 million in a series A funding round to develop a small-molecule treatment for alopecia and other types of hair loss. The Los Angeles–based biotechnology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results